| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/17/2009 | CA2506016C 3-amino-piperidine derivatives and processes for their preparation |
| 03/12/2009 | WO2009032326A1 New tetracycline derivatives as antiinfective agents |
| 03/12/2009 | WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 03/12/2009 | WO2008145524A3 4,4-disubstituted piperidine derivatives |
| 03/12/2009 | WO2007092681A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 03/12/2009 | US20090069469 Nitroxide Compounds for Minimizing Scorch in Crosslinkable Compositions |
| 03/12/2009 | US20090069378 Deuterium-enriched donepezil |
| 03/12/2009 | US20090069375 Deuterium-enriched miglustat |
| 03/12/2009 | US20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/12/2009 | US20090069331 Guanidine derivatives as inhibitors of ddah |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069294 Organic Compounds |
| 03/12/2009 | US20090069287 Substituted azacycloalkanes useful for treating cns conditions |
| 03/12/2009 | US20090069280 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents |
| 03/12/2009 | US20090068120 Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same |
| 03/12/2009 | US20090065739 Liquid crystal compound having chloronaphthalene moiety, liquid crystal composition, and optical device |
| 03/11/2009 | EP2032742A2 Aqueous, alkaline bath, devoid of cyanide, for depositing electroplated zinc alloy coatings |
| 03/11/2009 | EP2032535A1 Spirocyclic nitriles as protease inhibitors |
| 03/11/2009 | EP2032534A1 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| 03/11/2009 | EP2032527A1 Process for alkenylating carboxamides |
| 03/11/2009 | EP2032118A1 Piperidinium compounds and cosmetic compositions containing them |
| 03/11/2009 | EP1940782B1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP0976722B1 Benzamidine derivatives |
| 03/11/2009 | CN101384582A Piperazine compounds useful as antagonists of C-C chemokines (CCR2B and CCR5) for the treatment of inflammatory diseases |
| 03/11/2009 | CN101381477A Hindered amine light stabilizer and synthetic method thereof |
| 03/11/2009 | CN100467449C Cyclic aminophenyl sulfamate derivative |
| 03/10/2009 | US7501519 reacting grignard reagents with chemical intermediate exo-1-(bi-cyclo[2.2.1]hept-5-en-2-yl)-3-piperidino-1-propanone, formed by conversion of exo-1-(bicyclo[2.2.1]hept-5-en-2-yl)-ethanone into an exo silyl enol ether, then reacting with N-methylenepiperidinium chloride |
| 03/10/2009 | US7501443 Flavaxate derivatives as muscarinic receptor antagonists |
| 03/10/2009 | US7501442 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-[2-((6-[2-(4-hydroxyphenyl)ethylamino]-hexanoyl)-methylamino)ethyl]piperidin-4-yl ester |
| 03/10/2009 | US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women |
| 03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | CA2394602C New modulators of dopamine neurotransmission |
| 03/05/2009 | WO2009010477A8 Piperidine-4-acetic acid derivatives and their use |
| 03/05/2009 | WO2008156828A8 Renin inhibitors |
| 03/05/2009 | WO2008118328A3 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds |
| 03/05/2009 | WO2008023258A8 Piperidine derivatives |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/05/2009 | US20090062344 Therapeutic substituted piperidone compounds |
| 03/05/2009 | US20090062342 Amines |
| 03/05/2009 | US20090062341 Nuclear receptor binding agents |
| 03/05/2009 | US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/05/2009 | US20090062339 Compositions and methods for selective inhibition of nicotine acetylcholine receptors |
| 03/05/2009 | US20090062296 Nitrooxyderivatives of prostaglandin amides, e.g., N-(3-(nitrooxy)propyl) 1R-[1 alpha (Z),2 beta (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenamide; reduced side effects,wider pharmacological activity, enhanced tolerability, long-acting hypotensive activity |
| 03/05/2009 | US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives |
| 03/05/2009 | US20090062278 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 03/05/2009 | US20090062271 Antithrombotic Diamides |
| 03/05/2009 | US20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 03/05/2009 | US20090062261 Nitrogen-containing heterocycle derivatives substituted with cyclic group |
| 03/05/2009 | US20090062260 Compounds and compositions as lxr modulators |
| 03/05/2009 | US20090062250 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
| 03/04/2009 | EP2030970A1 Allosteric modulators of metabotropic glutamate receptors |
| 03/04/2009 | EP2030963A2 Derivatives of 1-oxyl-4-hydroxy-or 4-amino-2,2,6,6-tetramethylpiperidine as polymerization inhibitors for (meth) acrylate monomers |
| 03/04/2009 | EP2029596A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 03/04/2009 | EP2029541A1 Process for preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carboxylic acids |
| 03/04/2009 | EP2029540A2 Benzamide derivatives and uses related thereto |
| 03/04/2009 | EP2029539A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 03/04/2009 | EP2029538A1 Benzylpiperazine derivatives as motilin receptor antagonists |
| 03/04/2009 | EP1660443B1 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | CN101379033A Secondary amines |
| 03/04/2009 | CN101379032A Crystalline form of remifentanil hydrochloride |
| 03/04/2009 | CN101379030A Sulfonamide derivatives to treat infection with hepatitis c virus |
| 03/04/2009 | CN101379028A Chemical compounds |
| 03/04/2009 | CN101378756A Piperidine derivatives as CXCR3 receptor antagonists |
| 03/04/2009 | CN100465161C A preparation method of argatroban intermediates |
| 03/03/2009 | US7498460 Isophthalic acid derivatives |
| 03/03/2009 | US7498443 Process for production of carebastine |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498346 Chemokine receptor binding compounds |
| 03/03/2009 | US7498344 E.g., 4-[4-(4-fluoro)phenoxy]pheny-1-(2-phenyl-2-oxoethyl)-4-piperidinol; antiischemic agents; antiepilptic agents; relief of symptoms form seizures and migraines; calcium channel blockers (T-type Ca2+ channel); brain disorders; cardiovascular disorders |
| 02/26/2009 | WO2007014226A3 Compounds for the treatment of neurodegeneration and stroke |
| 02/26/2009 | US20090054630 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 02/26/2009 | US20090054500 Composition and methods useful in preventing cardiac hypertrophy |
| 02/26/2009 | US20090054486 Polymorphic form xvi of fexofenadine hydrochloride |
| 02/26/2009 | US20090054457 Substituted heterocyclic compounds |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054436 anticarcinogenic compounds; ; N-(4-(2-Aminopyridin-4-yloxy)-3-fluorophenyl)-2-bromoisonicotinamide, trifluoroacetic acid salt; inhibit the protein tyrosine kinase activity of growth factor receptors like Hepatocyte growth factor |
| 02/26/2009 | US20090054435 Phenoxyalkanoic Acid Compound |
| 02/26/2009 | US20090054431 Novel heterocycle compounds |
| 02/26/2009 | US20090053721 Voltage-gated ion channel mutants for use in identifying ion channel modulating compounds |
| 02/26/2009 | US20090053641 Charge control agent and related art |
| 02/26/2009 | CA2697256A1 Cyclopropyl amide derivatives |
| 02/25/2009 | EP2028185A1 Tubulysin and tubulysin agent |
| 02/25/2009 | EP2027137A1 Imino and amino sugar purification |
| 02/25/2009 | EP2027090A2 Mglur5 modulators ii |
| 02/25/2009 | EP2027089A1 Impurities of donepezil |
| 02/25/2009 | EP2027087A2 Intracellular kinase inhibitors |
| 02/25/2009 | EP1836168B1 Benzoyl-tetrahydropyridine as glyt-1 inhibitors |
| 02/25/2009 | EP1701939B1 Anthraquinone compounds as anti cancer compounds |
| 02/25/2009 | CN101374825A Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
| 02/25/2009 | CN101374813A Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders |
| 02/25/2009 | CN101374812A Process for synthesizing remifentanil |
| 02/25/2009 | CN101374811A Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations |
| 02/25/2009 | CN101374810A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 02/25/2009 | CN101374807A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |